Inspire Medical Systems (INSP) Competitors $80.94 -1.86 (-2.25%) As of 03:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INSP vs. PEN, STVN, GKOS, IRTC, BLCO, TMDX, SLNO, NVST, LIVN, and WRBYShould you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. Inspire Medical Systems vs. Its Competitors Penumbra Stevanato Group Glaukos iRhythm Technologies Bausch + Lomb TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems (NYSE:INSP) and Penumbra (NYSE:PEN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability. Which has more risk and volatility, INSP or PEN? Inspire Medical Systems has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Which has stronger valuation & earnings, INSP or PEN? Inspire Medical Systems has higher earnings, but lower revenue than Penumbra. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$802.80M2.98$53.51M$1.7346.78Penumbra$1.28B8.36$14.01M$3.7672.99 Do institutionals & insiders hold more shares of INSP or PEN? 94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 4.2% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to INSP or PEN? In the previous week, Inspire Medical Systems and Inspire Medical Systems both had 14 articles in the media. Inspire Medical Systems' average media sentiment score of 1.32 beat Penumbra's score of 1.05 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 10 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 10 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer INSP or PEN? Inspire Medical Systems presently has a consensus price target of $164.50, suggesting a potential upside of 103.25%. Penumbra has a consensus price target of $302.93, suggesting a potential upside of 10.38%. Given Inspire Medical Systems' higher probable upside, equities analysts plainly believe Inspire Medical Systems is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 6 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.57Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88 Is INSP or PEN more profitable? Penumbra has a net margin of 11.54% compared to Inspire Medical Systems' net margin of 6.17%. Penumbra's return on equity of 11.55% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems6.17% 10.38% 8.93% Penumbra 11.54%11.55%8.76% SummaryPenumbra beats Inspire Medical Systems on 10 of the 16 factors compared between the two stocks. Get Inspire Medical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INSP vs. The Competition Export to ExcelMetricInspire Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$2.39B$2.13B$5.82B$21.54BDividend YieldN/AN/A5.69%3.53%P/E Ratio46.6735.8374.6729.80Price / Sales2.9814.03454.5451.04Price / Cash46.1056.3537.0824.52Price / Book3.5211.7012.184.59Net Income$53.51M-$63.67M$3.29B$1.00B7 Day Performance-6.32%-0.36%1.08%0.80%1 Month Performance-3.80%5.32%7.32%4.79%1 Year Performance-60.24%37.70%63.11%16.13% Inspire Medical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INSPInspire Medical Systems4.9024 of 5 stars$80.94-2.3%$164.50+103.2%-60.0%$2.39B$802.80M46.671,246Positive NewsPENPenumbra4.6088 of 5 stars$272.96+0.5%$300.47+10.1%+36.8%$10.65B$1.19B72.604,500STVNStevanato Group1.9419 of 5 stars€23.14-1.4%N/A+33.9%€7.01B€1.19B42.855,521Gap UpGKOSGlaukos4.7233 of 5 stars$95.86-0.7%$127.42+32.9%-30.3%$5.50B$383.48M-58.10780News CoveragePositive NewsAnalyst ForecastIRTCiRhythm Technologies1.3359 of 5 stars$169.98-0.9%$163.82-3.6%+141.9%$5.46B$591.84M-58.012,000News CoveragePositive NewsBLCOBausch + Lomb2.0783 of 5 stars$14.63+0.6%$15.56+6.3%-3.2%$5.18B$4.79B-18.7613,500News CoveragePositive NewsTMDXTransMedics Group2.9272 of 5 stars$114.96-1.5%$123.00+7.0%-18.6%$3.92B$531.29M59.57210SLNOSoleno Therapeutics4.3712 of 5 stars$67.67-1.1%$115.09+70.1%+16.8%$3.60BN/A-16.3530Trending NewsAnalyst UpgradeShort Interest ↑Analyst RevisionNVSTEnvista3.9416 of 5 stars$21.15-0.5%$20.92-1.0%+22.5%$3.51B$2.55B66.0812,700Positive NewsLIVNLivaNova2.8931 of 5 stars$56.37+1.7%$59.71+5.9%+20.8%$3.08B$1.31B-14.492,900Positive NewsWRBYWarby Parker1.6999 of 5 stars$26.16-0.3%$24.06-8.0%+96.3%$2.75B$821.35M-373.723,030Positive NewsInsider Trade Related Companies and Tools Related Companies Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives iRhythm Technologies Alternatives Bausch + Lomb Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives Envista Alternatives LivaNova Alternatives Warby Parker Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INSP) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INSP Stock Alerts